Dell calls for absolute restrictions on autonomous AI software
Michael Dell says companies must define what AI agents cannot do, as Nvidia launches a safety platform with over 100 partners.
Oura's IPO sees four times demand, but the oversubscription may indicate market scarcity rather than genuine investor conviction.
Oura (OURA) has seen approximately four times as many orders as shares available for its IPO, with pricing scheduled for Tuesday.
The strong demand has already moved pricing towards the upper end of the proposed range. This surge comes after a sparse year for billion-dollar listings, leading to questions about the true driver of the interest.
A syndicate of five banks, among them Goldman Sachs and Morgan Stanley, is marketing 50 million shares. The price range is $40 to $44 per share, and orders have been about four times the number of shares on offer.
At the high end of the range, Oura's market capitalization would hit $14.1 billion. Bloomberg estimates the fully diluted valuation at more than $15 billion.
Oura targets US$15.62 billion valuation in U.S. IPO, setting stage for fall listings https://t.co/BErPj3ZV4W
— BNN Bloomberg (@BNNBloomberg) September 21, 2026
Such demand appears less remarkable given the sparse IPO calendar in 2026. Kraken's parent company delayed its own plans to go public until 2027. Nuclear services provider Holtec Nuclear and insurer Bamboo Insurance Services also put their offerings on hold, each citing market conditions within days of one another.
Oura's offering might be the first to surpass $1 billion since Jersey Mike's went public in July. Scarcity rather than strong conviction may be largely responsible for the pricing.
Former New York Fed president Bill Dudley has independently cautioned that stocks are broadly in bubble territory. That environment benefits a few well-packaged and well-marketed offerings.
Oura's earlier filing for the IPO demonstrated actual growth. Revenue increased 74% to $1.21 billion over nine months, and the number of paid members doubled to five million.
Net income rose to $60.8 million from $1.6 million a year earlier. Oura still reported a $924.3 million loss attributable to common shareholders, but that loss was due to a preferred-stock buyback, not the core operations.
Oura’s IPO could be worth up to $2.2 billion, but the more revealing number is 73%.
— Hurratul Maleka Taj (@Hurratul) September 25, 2026
In the base offering, 73% of the shares are secondary shares being sold by existing shareholders, while only 27% are primary shares sold by Oura.
The lesson: headline IPO size does not tell… pic.twitter.com/ZKIxWzmq7j
Hardware remains the primary revenue source. Ring sales generated $974 million compared to $240.5 million from subscriptions. This revenue mix more closely resembles a hardware company than the software valuation multiple Oura is being marketed under.
Whoop's $575 million fundraising at a $10.1 billion valuation tells a comparable story. Investors are applying generous valuations to the entire wearable sector, not just Oura.
Being four times oversubscribed informs underwriters about order allocation. It is far less indicative of the stock's performance after listing.
Ultimately, members will determine if the subscription cost of the ring is justified by the data it provides.
Share to
Disclaimer: this article comes from third-party media and is provided for reference only. It does not constitute investment advice. Crypto and other financial products carry significant price volatility risk, so please make your own decisions carefully.
Michael Dell says companies must define what AI agents cannot do, as Nvidia launches a safety platform with over 100 partners.
SpaceX shares fell 0.93% despite Starship's successful orbital flight, as a lockup expiry released 328 million shares into the market.
Ondas became the most failed-to-deliver US security in August, with short interest at 40.9% of its float. Investors blame short-sellers.
South Korean retail investors bought $1.6 billion in equities on Monday as the KOSPI slid 2.7%, going against foreign and institutional selling.